Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Türkiye
12 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2CompletedA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Ankara
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409 · EU 2023-508703-21-00 - Phase 3Taking peopleEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- Ankara, Antalya, Edirne, Istanbul
- Age
- 18 years and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Ankara, Bağcılar, Izmir
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - No phaseNot yet taking people in TürkiyeCHARM Hepatocellular Carcinoma MEA Study
- Where
- Ankara, Erzurum, Istanbul, Izmir
- People
- 4,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07650773 - Phase 3Taking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Altındağ, Antalya, Istanbul, Izmir, Mezitli, Yakutiye
- Age
- 18 years to 99 years
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - Phase 3Taking peoplePhase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Where
- Altındağ, Ankara, Erzurum, Istanbul, Izmir
- Age
- 18 years and over
- People
- 1,220 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00 - Phase 3Taking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Ankara, Erzurum, Istanbul, Konya, Seyhan
- Age
- 18 years and over
- People
- 1,100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Ankara, Cordaleo, Edirne, Kadıkoy/Istanbul, Konya, Pamukkale, Samsun
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - No phaseTaking peopleTransdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain
- Where
- Ankara
- Age
- 18 years and over
- People
- 56
- Run by
- Ankara Etlik City Hospital
See details and how to joinNCT07445386 - No phaseTaking peopleRAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study
- Where
- Adana, Ankara, Denizli, Diyarbakır, Istanbul, Izmir, Kayseri, Kocaeli, Konya, Malatya, Mersin
- Age
- 18 years and over
- People
- 150
- Run by
- Ankara University
See details and how to joinNCT07345247 - No phaseTaking peopleNeedle-based Percutaneous Ablation of Liver Tumors.
- Where
- Topkapı
- Age
- 18 years to 100 years
- People
- 31
- Run by
- inTumo Therapeutics, Inc.
See details and how to joinNCT06689670 - No phaseEnrolling by invitationInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Yenimahalle
- Age
- 1 day and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906